arrow
J

Jaydira Del Rivero

National Cancer Institute
H指数:26
被引数:2,470

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Expanded GEP-NET organoid culture for personalized therapy evaluation

扩展的GEP-NET类器官培养用于个性化疗法评估

2026-07-240
OA
Diagnostic work-up in paediatric adrenocortical tumours: an international consensus

儿科肾上腺皮质肿瘤的诊断评估:一项国际共识

2026-07-070
OAAI
CRISPR-Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer

基于CRISPR的基因依赖性筛选揭示间变性甲状腺癌中BRAF抑制剂耐药的机制

2026-04-260
OAAI
Belzutifan for Advanced Pheochromocytoma or Paraganglioma

Jimenez C, Andreassen M, Durand A, Moog S, Hendifar A, Welin S, 等人. LITESPARK-015 研究者团队. 贝zutifan治疗晚期嗜铬细胞瘤或副神经节瘤。新英格兰医学杂志。(2025)。doi: 10.1056/NEJMoa2504964

2025-10-014
PRE
A standardized surgical approach to multifocal locoregionally recurrent left-sided adrenocortical carcinoma

一种标准化的手术方法,用于治疗多灶性局部区域复发的左侧肾上腺皮质癌

2025-08-160
PRE
Prognostic Nomogram Predicting Survival and Propensity Score Matching with Demographics and Comparative Analysis of Prostate Small Cell and Large Cell Neuroendocrine Carcinoma
2024-08-180
OAAI